News from

New INFRAFRONTIER Article Published in Journal Mammalian Genome

A new publication of INFRAFRONTIER in Mammalian Genome is available on line now. Get an overview of the latest INFRAFRONTIER advancements, including services, resources, and technical developments.

Record participation in COVID-19 Open Call – five projects selected

The interest in the scientific community to fight the pandemic using mouse models is remarkably high. In December 2020, INFRAFONTIER launched an attractive free-of-charge service for the biomedical research community fighting against the COVID-19 pandemic: The COVID-19 Therapeutics Pipeline Trans-national Access (TA) Call offered academic researchers to test their novel therapeutics and vaccine candidates in a preclinical Bio-Safety Level 3 (BSL3) pipeline using COVID-19 optimized mouse models

Phenomin invites biomedical researchers from all over Europe to its Advanced School for Mouse Phenogenomics, 20 – 24 May 2019

It´s a unique training event for of all kinds of biomedial scientists working with mouse models – held in a fascinating location: The bi-annually organized European Advanced School for Mouse Phenogenomics, taking place on 20 to 24 May 2019 near Strasbourg, offers an overview of up-to-date methods and good practices for the use of mouse models in scientific research that cannot be found anywhere else in Europe.

Upcoming Training Courses in Mouse Phenogenomics at phenomin

• Strasbourg, France, 2016 November 09th-10th –In vivo CRISPR-Cas9 genome editingNEW!
• Strasbourg, France, 2016 November 23th-25th –Primary phenotyping of mouse embryos
• Strasbourg, France, 2017,March 14th-17th –Mouse models for diseases: approaches in phenotyping
• Goersdorf, France, 2017, June 12th-16th– 2d advanced European school in mouse phenogenomics

France, Greece, Czech Republic and Finland enter the INFRAFRONTIER GmbH

In a formal act authenticated by a notary in Munich, four founding members acquired shares of the INFRAFRONTIER GmbH: the Centre National de la Recherche Scientifique (CNRS) from France, the Biomedical Sciences Research Center ‘Alexander Fleming’ from Greece, the Institute of Molecular Genetics of the Acedemy of Sciences of the Czech Republic, and the University of Oulu in Finland.